Abstract
Catherine O. Johnson, Madineh Abbasi, Hedayat Abbastabar, Samar Abd ElHafeez, Nadin M. Abdel Razeq, Ahmed Abdelrahman Abdelgalil, Ali Abdolizadeh, Mostafa Abdrabou, Auwal Abdullahi, Tesfaye Birhanu Abebe, Asrat Agalu Abejew, Olumide Abiodun, Shady Abohashem, Mostafa A. Aboouf, Dmitry Abramov, Dariush Abtahi, Fuad Hamdi Abuadas, Eman Abu-Gharbieh, Ahmad Y. Abuhelwa, Kamoru Ademola Adedokun, Oluwatobi Emmanuel Adegbile, Nurudeen A. Adegoke, Olumide Thomas Adeleke, Makinde Adebayo Adeniyi, Miracle Ayomikun Adesina, Ridwan Olamilekan Adesola, Kishor Adhikari, Molalign Aligaz Adisu, Clifford Afoakwah, Mohammad Aghaali, Feleke Doyore Agide, Cesar Agostinis Sobrinho, Piyush Agrawal, Williams Agyemang-Duah, Danish Ahmad, Muayyad Ahmad, Saheem Ahmad, Suhaib Ahmad, Sepideh Ahmadi, Sarina Ahmadian, Muktar Beshir Ahmed, Syed Anees Ahmed, Marjan Ajami, Aanuoluwatimileyin Ibukunoluwa Ajayi, Salah Thabit Al Awaidy, Tariq Al Bahhawi, Mohammad Khaled Al Nawayseh, Yazan Al Thaher, Mohammad Ahmmad Mahmoud Al Zoubi, Fares Alahdab, Mohammad M. Al-Ahmad, Samer O. Alalalmeh, Rabail Alam, Fahad Alanezi, Fahmi Y. Al-Ashwal, Rashid Alavi, Mohammed Sad ALBashtawy, Khalifah A. Aldawsari, Nader Al-Dewik, Shereen M. Aleidi
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Prevalence, incidence and survival of heart failure: a systematic review.
10.1136/heartjnl-2021-320131 · 2022
Implementing guideline-directed medical therapy for heart failure: JACC focus seminar 1/3.
10.1016/j.jacc.2023.03.430 · 2023
Global impact of optimal implementation of guideline-directed medical therapy in heart failure.
10.1001/jamacardio.2024.3023 · 2024
A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction.
10.1016/j.jchf.2021.09.004 · 2022
Economic burden of heart failure in Europe: a systematic review of costs and cost-effectiveness.
10.1002/ehf2.70017 · 2025
Contemporary economic burden in a real-world heart failure population with commercial and Medicare supplemental plans.
10.1002/clc.23585 · 2021
Economic issues in heart failure in the United States.
10.1016/j.cardfail.2021.12.017 · 2022
Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement.
10.1016/s0140-6736(16)30388-9 · 2016
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
10.1016/s0140-6736(25)01917-8 · 2025
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure.
10.1016/j.cardfail.2021.01.022 · 2021
2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
10.1016/j.jacc.2021.12.012 · 2022
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
10.1016/s0140-6736(25)01637-x · 2025
Global, regional, and national burden of Chagas disease, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
10.1016/s1473-3099(25)00562-6 · 2026
Prevention of coronary heart disease by diet and lifestyle: evidence from prospective cross-cultural, cohort, and intervention studies.
10.1161/hc0702.103728 · 2002
Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations (monitoring trends and determinants in cardiovascular disease).
10.1016/s0140-6736(99)04021-0 · 1999
Coronary heart disease mortality trends during 50 years as explained by risk factor changes: the European cohorts of the Seven Countries Study.
10.1177/2047487318821250 · 2020
Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study.
10.1016/s2214-109x(17)30196-1 · 2017
Clinical profiles and outcomes of heart failure in five African countries: results from INTER-CHF Study.
10.5334/gh.940 · 2021
Global variations in heart failure etiology, management, and outcomes.
10.1001/jama.2023.5942 · 2023
International registry to assess medical practice with longitudinal observation for treatment of heart failure (REPORT-HF): rationale for and design of a global registry.
10.1002/ejhf.262 · 2015
Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry.
10.1002/ejhf.2431 · 2022
The Heart Failure Association Atlas: heart failure epidemiology and management statistics 2019.
10.1002/ejhf.2143 · 2021
A cluster-randomized, controlled trial of a simplified multifaceted management program for individuals at high cardiovascular risk (SimCard Trial) in Rural Tibet, China, and Haryana, India.
10.1161/circulationaha.115.015373 · 2015
Alcoholic cardiomyopathy: an update.
10.1093/eurheartj/ehae362 · 2024
Methamphetamine-associated heart failure: a systematic review of observational studies.
10.1136/heartjnl-2022-321610 · 2023
Methamphetamine-related cardiovascular diseases.
10.1002/ehf2.12572 · 2020
Unresolved referenced work
Kept as external metadata until matched
No additional external references are available.